February 3, 2023
Pharmabiz
Cipla consolidated net up 6.5% in Q3 to Rs. 807 crore
Cipla, a Rs. 21,600 crore plus pharma major, has posted single digit growth in revenues as well as pr... See more »
Carl Stuart: Calibre Scientific Acquires Carl Stuart Group
LOS ANGELES, Oct. 25, 2021 (GLOBE NEWSWIRE) - Calibre Scientific is pleased to announce the acquisition of Carl Stuart Group, a laboratory... Read More The post Calibre Scientific Acquires Carl Stuart Group appeared first on citybiz.
Read full article »
February 3, 2023
MarketScreener
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
(marketscreener.com) Bristol Myers Squibb today announced that the company will take part in a firesi... See more »
February 3, 2023
Contract Pharma
Lilly 4Q Revenues Down 9% to $7.3B
COVID-19 antibodies revenue was down 96% in the quarter to $38.0 million and down 10% for the year to... See more »
February 3, 2023NS Medical Devices
Abbott secures CE mark for TactiFlex, FDA nod for FlexAbility ablation catheters
The post Abbott secures CE mark for TactiFlex, FDA nod for FlexAbility ablation catheters appeared fi... See more »
February 6, 2023Independent
GlaxoSmithKline tops new business gender equality index
The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, ... See more »
February 5, 2023Nasdaq
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ),... See more »
February 3, 2023Pharamceutical Technology
Merck reports 2% increase in worldwide sales in Q4 2022
Merck recorded a 1% rise in pharmaceutical sales to $12.18bn compared to $12.03bn in the prior-year q... See more »
February 4, 2023Business Standard
HC directs firm to pay Rs 2 crore damages to Pfizer for contempt of court
The Delhi High Court has directed a firm to pay Rs 2 crore as damages to pharma giant Pfizer Inc for ... See more »
February 3, 2023PharmaTimes
Green light for AbbVie's Crohn's disease therapy Rinvoq
MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn's Disease... See more »
February 3, 2023
Pharmabiz
Cipla consolidated net up 6.5% in Q3 to Rs. 807 crore
Cipla, a Rs. 21,600 crore plus pharma major, has posted single digit growth in revenues as well as pr... See more »
February 3, 2023
MarketScreener
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
(marketscreener.com) Bristol Myers Squibb today announced that the company will take part in a firesi... See more »
February 3, 2023
Contract Pharma
Lilly 4Q Revenues Down 9% to $7.3B
COVID-19 antibodies revenue was down 96% in the quarter to $38.0 million and down 10% for the year to... See more »
February 3, 2023NS Medical Devices
Abbott secures CE mark for TactiFlex, FDA nod for FlexAbility ablation catheters
The post Abbott secures CE mark for TactiFlex, FDA nod for FlexAbility ablation catheters appeared fi... See more »
February 6, 2023Independent
GlaxoSmithKline tops new business gender equality index
The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, ... See more »
February 5, 2023Nasdaq
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ),... See more »
February 3, 2023Pharamceutical Technology
Merck reports 2% increase in worldwide sales in Q4 2022
Merck recorded a 1% rise in pharmaceutical sales to $12.18bn compared to $12.03bn in the prior-year q... See more »
February 4, 2023Business Standard
HC directs firm to pay Rs 2 crore damages to Pfizer for contempt of court
The Delhi High Court has directed a firm to pay Rs 2 crore as damages to pharma giant Pfizer Inc for ... See more »
February 3, 2023PharmaTimes
Green light for AbbVie's Crohn's disease therapy Rinvoq
MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn's Disease... See more »
Managing Director
Michael Anderson